MedTrace Logo

Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma

NCT00142025 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether antiepileptic drug oxcarbazepine is effective in the treatment of chronic asthma.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Oxcarbazepine

Sponsors & Collaborators

  • Rea Rehabilitation Centre, Georgia

    collaborator OTHER

  • Centre of Chinese Medicine, Georgia

    lead OTHER

Principal Investigators

  • Merab Lomia, MD, PhD · "Rea" Rehabilitation Centre.

  • Manana Tchaia, MD · Centre of Chinese Medicine

  • Tamara Tchelidze, MD · CRO Evidence

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Completion
2002-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00142025 on ClinicalTrials.gov